A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis
ClinicalTrials.gov ID
NCT00333814
Lead Sponsor
AllerganINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 2Phase 3
Enrollment
229Actual
Last Update Posted
Apr 14, 2011Estimated
Start Date
May 2006
Primary Completion Date
Dec 2008Actual
Completion Date
Apr 2009Actual
Brief Summary
This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of non-infectious intermediate or posterior uveitis.
Intermediate Uveitis
Posterior Uveitis
Dexamethasone
dexamethasone
Sham injection
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
18 years or older with a diagnosis of chronic intermediate uveitis in at least one eye